Thomas Jefferson University Hospital
 
DIVISION OF GASTROENTEROLOGY & HEPATOLOGY

News

Jefferson Hospital Ranked by US News & World Report U.S.News & World Report this year named Jefferson University Hospital as among the best in the nation in digestive disorders.
Jefferson Hospital President and CEO Thomas J. Lewis said Jefferson and its staff are again honored to be among a select number of medical centers of excellence in the nation. “We are constantly striving to provide the best care and treatment possible for patients and it’s clear from this survey that U.S.News & World Report concurs,” Mr. Lewis said.

Whipple Webcast at Jefferson Highlights Innovative Surgical Treatment for Pancreatic Cancer
(Published: 08-27-2007) Thomas Jefferson University Hospital will host a webcast featuring a mini-Whipple procedure (pylorus preserving pancreaticoduodenectomy) used to treat pancreatic cancer. The webcast, which will feature an actual procedure and panel discussion by the Jefferson Pancreatic Cancer and Related Diseases team, is scheduled for 4:30 p.m. ET on Tuesday, September 18, at www.JeffersonHospital.org/webcast.


Colon Cancer a Disease of Hormone Deficiency, Jefferson Team Finds
(Published: 08-01-2007) Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have found new evidence suggesting that colon cancer is actually a disease of missing hormones that could potentially be treated by hormone replacement therapy.


Jefferson GI Researchers Use SpyGlass System To Provide Better Diagnoses of Digestive Problems
(Published: 06-13-2007) Patients in the Digestive Disease Institute at Thomas Jefferson University Hospital can benefit from a new generation of endoscopes that enable physicians to provide an earlier and better diagnosis of diseases involving the bile duct.


Anthony DiMarino, M.D. to be Honored at National Gastroenterology Conference
(Published: 05-18-2007) Anthony DiMarino, M.D., director of the division of Gastroenterology and Hepatology at Thomas Jefferson University and Hospital, will be honored as an AGA (American Gastroenterological Association) Foundation Mentor at the 2007 Digestive Disease Week (May 19 to 24) in Washington, D.C.


Jefferson Researchers Present at DDW
(Published: 05-18-2007) The following summaries are based on presentations by Thomas Jefferson University Researchers at Digestive Disease Week 2007 in Washington, D.C.


Identify the Cancer to be Treated, Jefferson Researchers Recommend
(Published: 05-04-2007) With the increase in specifically tailored therapies for individual cancers, Jefferson doctors suggest that making a proper diagnosis takes on even greater significance.


Jefferson Researcher Awarded $1.6 Million to Study Mechanisms of Gastrointestinal Disorders
(Published: 01-17-2007) Gastroenterology researcher Satish Rattan, DVM, professor of medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, has been awarded $1.6 million from the National Institutes of Health to study the molecular mechanisms involved in maintaining smooth muscle tone of the internal anal sphincter (IAS), which is crucial for normal bowel functioning.


Jefferson GI Physicians Offer an Easier Way to Find and Treat Disorders of the Small Intestine
(Published: 01-03-2007) First there was the swallowed camera, a device to take doctors on an incredible journey through a patient’s small intestine. Now, at Thomas Jefferson University Hospital, another innovation lets them make a stop along the way.


Stop the waist! Why obesity is weighing down the nation
(Published: 11-30-2006, Jewish Exponent) Fat jokes -- never funny to begin with -- really aren't funny these days. In fact, they're downright unpleasant.

"Obesity contributes to what's known as metabolic syndrome -- hypertension, high triglycerides, insulin resistance, high cholesterol and excess abdominal fat around the waist -- a cluster of conditions that occur together increasing the risk of heart disease, stroke and diabetes," explained Emily Rubin, a registered dietitian in the division of gastroenterology and hepatalogy at Thomas Jefferson University Hospital .

"The danger is that there is food everywhere today, but decreasing calories by 500 a day means losing one pound a week."

"Try to make it fun; make a change in behavior, a lifestyle change. Three small meals a day and three small snacks is a good approach because it's all about portion size. Low-fat is better than high-fat, but be mindful of calories,” explains Rubin.

Media Coverage:
Jewish Exponent


Barrett's Esophagus, Fastest Growing Cancer
(Published 11-08-06, CBS 3) A cancer of the esophagus is the fastest growing cancer in the United States.

Over time, acid reflux can cause cells in the esophagus to become abnormal. Anthony Infantolino, M.D., gastroenterologist at Thomas Jefferson University Hospital, says, "We want to intervene long before the patient ever gets close to cancer."

Using the BARRX, a procedure Dr. Infantolino uses a scope to ablate the suspicious cells in the esophagus. Dr. Infantolino is conducting a study with the BARRX device.
Gastroenterology and Hepatology

Media Coverage:
CBS 3


Patricia Kozuch, M.D. Joins Division of Gastroenterology and Hepatology at Jefferson
(Published: 09-13-2006) To meet the needs of a significant population of patients who suffer from inflammatory bowel disease (IBD), Patricia L. Kozuch, M.D., is joining the Division of Gastroenterology and Hepatology in the Department of Medicine at Thomas Jefferson University and Thomas Jefferson University Hospital.


Enzyme Inhibitor May Provide New Strategy for Treating Certain Gastrointestinal Disorders, Jefferson Researchers Find
(Published: 07-17-2006) Drugs that block the activity of an enzyme might hold a key to treating chronic and severe disorders such as certain forms of constipation, hemorrhoids, anal fissures, Hirschsprung’s disease and other similar gastrointestinal problems.


Thomas Jefferson University Hospital Ranked Best Hospital in Philadelphia for Orthopaedics and Rehabilitation Medicine by U.S.News & World Report
(Published: 07-10-2006) U.S.News & World Report this year also ranked Jefferson University Hospital as among the best in the nation in six other specialties – cancer; digestive disorders; ear, nose and throat; endocrinology; kidney disease; and urology.

American Liver Foundation Honors Jefferson’s Transplant Program Director as Physician of the Year
(Published: 06-13-2006) Victor J. Navarro, M.D., Recognized for Impact on Thousands of Patients and Families


Procedure for Patients at Risk for Esophageal Cancer being studied at Thomas Jefferson University Hospital
(Published: 05-31-2006) A new nonsurgical procedure for people who suffer from Barrett’s Esophagus is being studied at Thomas Jefferson University Hospital in Philadelphia.


Procedure for Patients at Risk for Esophageal Cancer being studied at Thomas Jefferson University Hospital
(Published: 05-19-2006) A new nonsurgical procedure for people who suffer from Barrett’s Esophagus is being studied at Thomas Jefferson University Hospital in Philadelphia.


Hepatitis C: Learn All About the Epidemic
(Published: 03-24-2006) A free seminar to provide timely and important information to people who suffer from hepatitis C, along with their friends and families, will be held on Saturday, April 22 , from 8:15 am to 1 pm at Thomas Jefferson University.


At Jefferson HealthCARE-Voorhees: Meet Vince Papale, former Philadelphia Eagle, and his colon cancer specialists from Thomas Jefferson University Hospital
(Published: 03-14-2006) Vince Papale, a former Philadelphia Eagles wide receiver who beat the odds to become the oldest rookie in NFL history, will share his inspiring life story -- including his triumphant battle with colorectal cancer -- at Jefferson HealthCARE-Voorhees, on Wednesday, March 29 from 5:30 to 8 p.m.


Jefferson Liver Specialist in New England Journal of Medicine: New, expensive, widely-used drugs continue to cause liver problems

(Published: 02-17-2006) In an article published this week in the New England Journal of Medicine, lead author Victor J. Navarro, M.D., clinical associate professor of medicine at Jefferson Medical College, writes that liver injuries continue to plague the nation’s drug development system, proving very costly to pharmaceutical companies that spend millions of dollars on development. The federal Food and Drug Administration now wants better ways to detect these problem drugs before they reach the market and injure users.


Featured in the Media
Hidden danger is coming into focus

Celiac disease, an autoimmune disorder, often goes unrecognized or misdiagnosed, sometimes for decades. Until recently, doctors thought the condition affected only about one in 10,000 people and was confined mostly to childhood. It is now estimated that as many as three million people are affected.

The overwhelming majority of people with the affliction are unaware they have the condition, often because they don't have the textbook symptoms. Most patients "have a lot of subtle things," said Anthony DiMarino, M.D., director of Gastroenterology and Hepatology, in the department of Medicine at Thomas Jefferson University Hospital in Philadelphia.

With celiac disease, the body's immune system goes awry and attacks itself. People are born with a genetic predisposition, but it takes an environmental trigger, such as gluten, to initiate it.

Following a gluten-free diet, however, isn't easy. Emily Rubin, R.D., a registered dietitian in the division of Gastroenterology and Hepatology, likes to focus first on what patients can eat - fruits, vegetables, meat, potatoes and rice. "When a patient is first diagnosed, they are sort of in denial, because it involves a change in lifestyle," Rubin said. "It can be overwhelming at first."

Media Coverage:
The Philadelphia Inquirer


Jefferson Recruits Top Fundraiser
(Published: 01-31-2006) David R. Lepper is Newest Addition to Jefferson Executive Team